Skip to main content

Table 3 Indicating the results for Bayesian log-normal AFT model using INLA method

From: Assessing survival time of heart failure patients: using Bayesian approach

Covariates

Categories

Pmean

Sd

Median

Credible Interval

Mode

Kld

 

Intercept

4.953

0.221

4.945

[4.541, 5.409]*

4.929

0

Age

 ≤ 49–65

Ref

     

49–65

−0.258

0.115

−0.256

[−0.488, −0.036]*

−0.253

0

 ≥ 65

−0.336

0.110

−0.335

[−0.557, −0.125]*

−0.331

0

Hypertension

No

Ref

     

Yes

−0.301

0.076

−0.300

[−0.452, −0.153]*

−0.299

0

CKD

No

Ref

     

Yes

−0.389

0.075

−0.388

[−0.537, −0.244]*

−0.387

0

Etiology of Heart failure

IHD

Ref

     

RVHD

−0.302

0.116

−0.302

[−0.533, −0.076]*

−0.300

0

Cardiomyopathy

−0.158

0.113

−0.158

[−0.382, 0.063]

−0.157

0

HDD

−0.258

0.115

−0.257

[−0.486, −0.035]*

−0.255

0

Others

−0.381

0.160

−0.381

[−0.693, −0.066]*

−0.382

0

Smoking cigarette

No

Ref

     

Yes

−0.156

0.073

−0.155

[−0.300, −0.014]*

−0.154

0

Stages of Heart failure

I

Ref

     

II

−0.400

0.190

−0.397

[−0.782, −0.038]*

−0.389

0

III

−0.423

0.176

−0.419

[−0.781, −0.090]*

−0.410

0

IV

−0.506

0.173

−0.501

[−0.857, −0.180]*

−0.492

0

Diabetes mellitus

Not

Ref

     

Type I

−0.232

0.10

0.231

[−0.431, −0.036]*

−0.230

0

Type II

−0.422

0.086

−0.421

[−0.593, −0.255]*

−0.419

0

Anemia

No

Ref

     

Yes

−0.154

0.072

−0.153

[−0.298, −0.013]*

−0.152

0

Tau parameter

For log-normal

4.30

0.497

4.28

[3.38, 5.33]*

4.24

  1. Source: JUMC, Jimma, Ethiopia; from first January 2016 to first January 2019
  2. *Is indicated statistically significant. Pmean, Posterior Mean; CKD, Chronic kidney disease; IHD, Ischemic heart disease; RVHD, Rheumatic valvular heart disease; HHD, Hypertensive heart disease, Sd, Standard deviation, KLD, Kullback–Leibler Divergence